Erlotinib Hydrochloride in Treating Patients With Malignant Peritoneal Mesothelioma
Clinical trial NCT01592383 · COMPLETED
Trial details
- NCT number
- NCT01592383
- Sponsor
- University of Chicago
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-06-01
- Primary completion
- 2017-02-01
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.